Thus, our data show that Atg7 deficiency in the intestinal epithelium alone does not lead to altered responses to DSS treatment indicating that autophagy dysregulation in intestinal immune cells might play a more important role for the pathogenesis of IBD. This evidence concerns the gene ATG7 and inflammatory bowel disease.